Probi

Miss on Q3 sales (-12%) and EBITDA (-10%) vs ABGSCe China faced headwinds due to macroeconomic factors EBITDA revised down by 2-3% for '24e-'26e Encouraging B2C sales efforts in the Nordics Probi reported a soft Q3'24 with sales amounting to SEK 143....

Probi

Videopræsentation22.10.2024, 08.00

Probi, Audiocast with teleconference, Q3'24

Probi

Selskabsmeddelelse22.10.2024, 06.00

Probi: Q3 2024: Tangible improvement in operations

Probi

Pressemeddelelse17.10.2024, 06.50

Presentation of Probi's Q3 Report 2024

Probi

Pressemeddelelse16.10.2024, 11.30

Probi partners with Global BHP BrainTrust and the FINGERS Brain Health Institute to counteract dementia

Probi

Pressemeddelelse10.10.2024, 07.00

Nordic launch of Probi Sense - a unique dietary supplement for the mental capacity

Probi

Pressemeddelelse24.9.2024, 11.00

New study strengthens Probi[ ][®]s L. plantarum HEAL9[®] strain in cognitive function

Probi

Eksterne analyser17.7.2024, 06.29

Probi: FY'24e marks a transition to a promising future - ABG

- Beat on Q2 sales (+3%) and EBITDA (+24%) vs ABGSCe - EBITDA up 2% for '24e and 1% for '25e - Our comprehensive analysis indicates a promising long-term outlook Americas and EMEA progressed well in Q2 Probi reported a strong Q2'24 driven by growth in...

Probi

Probi

Bliv en del af Inderes community

Inderes konto

Bliv en del af Inderes community

Inderes konto